Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25433461 | 0.85 | MAPT (0.58) | MAPTLMNAKMT2AMEN1POLB | |
| Formic Acid SCHEMBL30584960 | 0.83 | MEN1 (0.61) | MAPTLMNAALDH1A1NPC1KMT2A | |
| SCHEMBL25433838 | 0.82 | MAPT (0.57) | MAPTLMNAKMT2AMEN1POLB | |
| Formic Acid SCHEMBL30584716 | 0.81 | MEN1 (0.49) | MAPTLMNAKMT2AMEN1POLB | |
| SCHEMBL30584744 | 0.78 | MEN1 (0.66) | MAPTLMNAALDH1A1NPC1KMT2A | |
| SCHEMBL25433804 | 0.75 | HRH3 (0.48) | MAPTLMNANPC1 | |
| SCHEMBL31667497 | 0.75 | MEN1 (0.52) | MAPTLMNAKMT2AMEN1POLB | |
| Hydrochloric Acid SCHEMBL31546373 | 0.74 | HRH3 (0.47) | MAPTLMNANPC1 | |
| Formic Acid SCHEMBL31546374 | 0.74 | CCR3 (0.56) | MAPTLMNAALDH1A1KMT2AMEN1 | |
| SCHEMBL25435779 | 0.74 | MAPT (0.53) | MAPTLMNAKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4463452-A2 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | Anima Biotech Inc. (US) | 2024-11-20 | — | — | EP | disclosed |
| WO-2023177700-A2 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2023-09-21 | — | — | WO | disclosed |